Classifying spatial patterns of brain activity with machine learning methods: application to lie detection.

PubWeight™: 2.92‹?› | Rank: Top 1%

🔗 View Article (PMID 16169252)

Published in Neuroimage on October 05, 2005

Authors

C Davatzikos1, K Ruparel, Y Fan, D G Shen, M Acharyya, J W Loughead, R C Gur, D D Langleben

Author Affiliations

1: Department of Radiology, University of Pennsylvania, 3600 Market Street, Suite 380, Philadelphia, PA 19104, USA. christos@rad.upenn.edu

Articles citing this

Machine learning classifiers and fMRI: a tutorial overview. Neuroimage (2008) 5.74

Representational similarity analysis - connecting the branches of systems neuroscience. Front Syst Neurosci (2008) 5.14

Alzheimer's disease diagnosis in individual subjects using structural MR images: validation studies. Neuroimage (2007) 4.41

Decoding subject-driven cognitive states with whole-brain connectivity patterns. Cereb Cortex (2011) 4.11

Spatial patterns of brain atrophy in MCI patients, identified via high-dimensional pattern classification, predict subsequent cognitive decline. Neuroimage (2007) 4.07

Analyzing for information, not activation, to exploit high-resolution fMRI. Neuroimage (2007) 3.62

Detection of prodromal Alzheimer's disease via pattern classification of magnetic resonance imaging. Neurobiol Aging (2006) 3.26

Structural and functional biomarkers of prodromal Alzheimer's disease: a high-dimensional pattern classification study. Neuroimage (2008) 2.93

Individual patient diagnosis of AD and FTD via high-dimensional pattern classification of MRI. Neuroimage (2008) 2.36

Encoding and decoding in fMRI. Neuroimage (2010) 2.08

Longitudinal progression of Alzheimer's-like patterns of atrophy in normal older adults: the SPARE-AD index. Brain (2009) 2.05

The contributions of prefrontal cortex and executive control to deception: evidence from activation likelihood estimate meta-analyses. Cereb Cortex (2008) 1.87

Inferring mental states from neuroimaging data: from reverse inference to large-scale decoding. Neuron (2011) 1.84

Machine learning and radiology. Med Image Anal (2012) 1.72

Support vector machine learning-based fMRI data group analysis. Neuroimage (2007) 1.67

What's new in neuroimaging methods? Ann N Y Acad Sci (2009) 1.53

Distributed representations in memory: insights from functional brain imaging. Annu Rev Psychol (2011) 1.44

Decoding the perception of pain from fMRI using multivariate pattern analysis. Neuroimage (2012) 1.28

Antemortem differential diagnosis of dementia pathology using structural MRI: Differential-STAND. Neuroimage (2010) 1.14

Analytic estimation of statistical significance maps for support vector machine based multi-variate image analysis and classification. Neuroimage (2013) 1.12

Testing simulation theory with cross-modal multivariate classification of fMRI data. PLoS One (2008) 1.11

Generative embedding for model-based classification of fMRI data. PLoS Comput Biol (2011) 1.10

Prediction of Alzheimer's disease and mild cognitive impairment using cortical morphological patterns. Hum Brain Mapp (2012) 1.09

Neural correlates of true memory, false memory, and deception. Cereb Cortex (2008) 1.06

Within- and cross-participant classifiers reveal different neural coding of information. Neuroimage (2010) 1.01

Local pattern classification differentiates processes of economic valuation. Neuroimage (2009) 0.99

Can neuroimaging help us to understand and classify somatoform disorders? A systematic and critical review. Psychosom Med (2011) 0.98

Applications of multivariate pattern classification analyses in developmental neuroimaging of healthy and clinical populations. Front Hum Neurosci (2009) 0.97

Unsupervised spatiotemporal fMRI data analysis using support vector machines. Neuroimage (2009) 0.97

Neural imaging to track mental states while using an intelligent tutoring system. Proc Natl Acad Sci U S A (2010) 0.96

A novel approach for lie detection based on F-score and extreme learning machine. PLoS One (2013) 0.95

A hybrid SVM-GLM approach for fMRI data analysis. Neuroimage (2009) 0.95

MRI markers for mild cognitive impairment: comparisons between white matter integrity and gray matter volume measurements. PLoS One (2013) 0.94

Using structural neuroanatomy to identify trauma survivors with and without post-traumatic stress disorder at the individual level. Psychol Med (2013) 0.93

Functional MRI at the crossroads. Int J Psychophysiol (2008) 0.92

Functional MRI detection of deception after committing a mock sabotage crime. J Forensic Sci (2008) 0.92

Detecting stable distributed patterns of brain activation using Gini contrast. Neuroimage (2010) 0.90

Do parkinsonian patients have trouble telling lies? The neurobiological basis of deceptive behaviour. Brain (2009) 0.88

Generating text from functional brain images. Front Hum Neurosci (2011) 0.87

Towards the identification of imaging biomarkers in schizophrenia, using multivariate pattern classification at a single-subject level. Neuroimage Clin (2013) 0.87

Multivariate pattern analysis reveals common neural patterns across individuals during touch observation. Neuroimage (2011) 0.86

Utilizing temporal information in fMRI decoding: classifier using kernel regression methods. Neuroimage (2011) 0.86

Predicting decisions in human social interactions using real-time fMRI and pattern classification. PLoS One (2011) 0.86

The role of neuroimaging in diagnosis and personalized medicine--current position and likely future directions. Dialogues Clin Neurosci (2009) 0.85

Model-based feature construction for multivariate decoding. Neuroimage (2010) 0.85

Using Brain Imaging for Lie Detection: Where Science, Law and Research Policy Collide. Psychol Public Policy Law (2013) 0.85

Replication of Functional MRI Detection of Deception. Open Forensic Sci J (2009) 0.84

Machine learning approaches: from theory to application in schizophrenia. Comput Math Methods Med (2013) 0.82

Pattern classification of valence in depression. Neuroimage Clin (2013) 0.82

Multivoxel pattern analysis for FMRI data: a review. Comput Math Methods Med (2012) 0.82

Prospects of functional magnetic resonance imaging as lie detector. Front Hum Neurosci (2013) 0.82

fMRI-activation patterns in the detection of concealed information rely on memory-related effects. Soc Cogn Affect Neurosci (2009) 0.82

Seven topics in functional magnetic resonance imaging. J Integr Neurosci (2009) 0.82

Feature selection for fMRI-based deception detection. BMC Bioinformatics (2009) 0.81

The neural correlates of identity faking and concealment: an FMRI study. PLoS One (2012) 0.81

Decoding semantics across fMRI sessions with different stimulus modalities: a practical MVPA study. Front Neuroinform (2012) 0.80

Using brain imaging to track problem solving in a complex state space. Neuroimage (2011) 0.79

Addressing Confounding in Predictive Models with an Application to Neuroimaging. Int J Biostat (2016) 0.79

Prediction of Successful Memory Encoding from fMRI Data. Med Image Comput Comput Assist Interv (2008) 0.78

Tracking problem solving by multivariate pattern analysis and Hidden Markov Model algorithms. Neuropsychologia (2011) 0.78

Survey of encoding and decoding of visual stimulus via FMRI: an image analysis perspective. Brain Imaging Behav (2014) 0.77

Detection of deception based on fMRI activation patterns underlying the production of a deceptive response and receiving feedback about the success of the deception after a mock murder crime. Soc Cogn Affect Neurosci (2013) 0.77

Spatially aggregated multiclass pattern classification in functional MRI using optimally selected functional brain areas. Magn Reson Imaging (2012) 0.77

Support vector machine learning-based cerebral blood flow quantification for arterial spin labeling MRI. Hum Brain Mapp (2014) 0.77

Automated classification of fMRI during cognitive control identifies more severely disorganized subjects with schizophrenia. Schizophr Res (2012) 0.77

Decoding Subjective Intensity of Nociceptive Pain from Pre-stimulus and Post-stimulus Brain Activities. Front Comput Neurosci (2016) 0.76

What makes a pattern? Matching decoding methods to data in multivariate pattern analysis. Front Neurosci (2012) 0.76

Neural correlates of deception: lying about past events and personal beliefs. Soc Cogn Affect Neurosci (2016) 0.75

Support vector machine classification of arterial volume-weighted arterial spin tagging images. Brain Behav (2016) 0.75

Brain response pattern identification of fMRI data using a particle swarm optimization-based approach. Brain Inform (2016) 0.75

Graph-based inter-subject pattern analysis of FMRI data. PLoS One (2014) 0.75

Visual prediction error spreads across object features in human visual cortex. J Neurosci (2016) 0.75

Using Graph Components Derived from an Associative Concept Dictionary to Predict fMRI Neural Activation Patterns that Represent the Meaning of Nouns. PLoS One (2015) 0.75

Editors' overview: Neuroethics: many voices and many stories. Sci Eng Ethics (2012) 0.75

Control-group feature normalization for multivariate pattern analysis of structural MRI data using the support vector machine. Neuroimage (2016) 0.75

A neural network approach to fMRI binocular visual rivalry task analysis. PLoS One (2014) 0.75

The neural mechanism of encountering misjudgment by the justice system. PLoS One (2013) 0.75

Decoding the processing of lying using functional connectivity MRI. Behav Brain Funct (2015) 0.75

What the success of brain imaging implies about the neural code. Elife (2017) 0.75

Memory and self-neuroscientific landscapes. ISRN Neurosci (2013) 0.75

A novel algorithm to enhance P300 in single trials: application to lie detection using F-score and SVM. PLoS One (2014) 0.75

Articles by these authors

Comparison of human genetic and sequence-based physical maps. Nature (2001) 4.97

Neuropsychological function in schizophrenia. Selective impairment in memory and learning. Arch Gen Psychiatry (1991) 3.88

Neuropsychological deficits in neuroleptic naive patients with first-episode schizophrenia. Arch Gen Psychiatry (1994) 3.59

Sequential Monte Carlo without likelihoods. Proc Natl Acad Sci U S A (2007) 3.42

Association between decline in brain dopamine activity with age and cognitive and motor impairment in healthy individuals. Am J Psychiatry (1998) 3.02

Mechanism of action of eukaryotic DNA topoisomerase I and drugs targeted to the enzyme. Biochim Biophys Acta (1998) 2.83

Current insights into the regulation of programmed cell death by NF-kappaB. Oncogene (2006) 2.60

Clinical subtypes of schizophrenia: differences in brain and CSF volume. Am J Psychiatry (1994) 2.27

Brain activity during simulated deception: an event-related functional magnetic resonance study. Neuroimage (2002) 2.26

A follow-up magnetic resonance imaging study of schizophrenia. Relationship of neuroanatomical changes to clinical and neurobehavioral measures. Arch Gen Psychiatry (1998) 2.24

Subcortical MRI volumes in neuroleptic-naive and treated patients with schizophrenia. Am J Psychiatry (1998) 2.09

The Polycomb group in Caenorhabditis elegans and maternal control of germline development. Development (1998) 1.97

Reduced dorsal and orbital prefrontal gray matter volumes in schizophrenia. Arch Gen Psychiatry (2000) 1.86

Association between age-related decline in brain dopamine activity and impairment in frontal and cingulate metabolism. Am J Psychiatry (2000) 1.85

Beta-synuclein gene alterations in dementia with Lewy bodies. Neurology (2004) 1.82

Phenotype and genotype of advanced premalignant head and neck lesions after chemopreventive therapy. J Natl Cancer Inst (1998) 1.78

Analysis of brain and cerebrospinal fluid volumes with MR imaging. Part I. Methods, reliability, and validation. Radiology (1991) 1.78

Emotion recognition deficit in schizophrenia: association with symptomatology and cognition. Biol Psychiatry (2000) 1.78

Facial emotion discrimination: I. Task construction and behavioral findings in normal subjects. Psychiatry Res (1992) 1.75

Olfactory identification deficits in schizophrenia: correlation with duration of illness. Am J Psychiatry (1997) 1.71

UV activates growth factor receptors via reactive oxygen intermediates. J Cell Biol (1996) 1.70

Age-related volumetric changes of brain gray and white matter in healthy infants and children. Cereb Cortex (2001) 1.69

Decreased Egr-1 expression in human, mouse and rat mammary cells and tissues correlates with tumor formation. Int J Cancer (1997) 1.66

Temporolimbic volume reductions in schizophrenia. Arch Gen Psychiatry (2000) 1.66

Relations among clinical scales in schizophrenia. Am J Psychiatry (1991) 1.65

Autophagy promotes necrosis in apoptosis-deficient cells in response to ER stress. Cell Death Differ (2007) 1.64

Normative neuropsychological test performance: effects of age, education, gender and ethnicity. Appl Neuropsychol (1995) 1.64

Sex and handedness differences in cerebral blood flow during rest and cognitive activity. Science (1982) 1.62

Local thrombolysis for severe cerebral venous sinus thrombosis. AJNR Am J Neuroradiol (2012) 1.57

Cognitive performance of male adolescents is lower than controls across psychiatric disorders: a population-based study. Acta Psychiatr Scand (2004) 1.57

Comparison of the continuous performance test with and without working memory demands in healthy controls and patients with schizophrenia. Schizophr Res (2001) 1.53

Reversion of the neoplastic phenotype of human glioblastoma cells by connexin 43 (cx43). Cancer Res (1998) 1.53

An isoform of eIF4E is a component of germ granules and is required for spermatogenesis in C. elegans. Development (2001) 1.53

Striatal dopamine transporters and cognitive functioning in healthy men and women. Am J Psychiatry (2001) 1.53

Olfactory dysfunction in schizophrenia: a qualitative and quantitative review. Neuropsychopharmacology (1999) 1.50

Characterization of a novel tumor-derived cytokine. Endothelial-monocyte activating polypeptide II. J Biol Chem (1994) 1.49

IFN-gamma knockout mice show Th2-associated delayed-type hypersensitivity and the inflammatory cells fail to localize and control chlamydial infection. Eur J Immunol (1999) 1.48

Emotional processing in schizophrenia: neurobehavioral probes in relation to psychopathology. Schizophr Res (1995) 1.47

Hemispheric asymmetry in the expression of positive and negative emotions. Neurologic evidence. Arch Neurol (1982) 1.43

Effect of abstinence challenge on brain function and cognition in smokers differs by COMT genotype. Mol Psychiatry (2008) 1.43

An upper limit on the stochastic gravitational-wave background of cosmological origin. Nature (2009) 1.42

Percutaneous vasal sperm aspiration and intrauterine insemination in the treatment of obstructive azoospermia. Fertil Steril (1997) 1.41

Human glutathione S-transferase P1-1 interacts with TRAF2 and regulates TRAF2-ASK1 signals. Oncogene (2006) 1.40

Neuropsychological evidence supporting a neurodevelopmental model of schizophrenia: a longitudinal study. Schizophr Res (1997) 1.38

Mining and visualizing large anticancer drug discovery databases. J Chem Inf Comput Sci (2000) 1.38

Characterization of the U(L)33 gene product of herpes simplex virus 1. Virology (2000) 1.37

Assessment of NMDA receptor NR1 subunit hypofunction in mice as a model for schizophrenia. Genes Brain Behav (2009) 1.37

In vitro pharmacological characterization of AM1241: a protean agonist at the cannabinoid CB2 receptor? Br J Pharmacol (2006) 1.37

Effect of schizophrenia on frontotemporal activity during word encoding and recognition: a PET cerebral blood flow study. Am J Psychiatry (2001) 1.35

Smaller neuron size in schizophrenia in hippocampal subfields that mediate cortical-hippocampal interactions. Am J Psychiatry (1995) 1.34

Emotions are expressed more intensely on the left side of the face. Science (1978) 1.31

Frontal and temporal lobe brain volumes in schizophrenia. Relationship to symptoms and clinical subtype. Arch Gen Psychiatry (1995) 1.31

Neuropsychological functioning in siblings discordant for schizophrenia and healthy volunteers. Arch Gen Psychiatry (1994) 1.31

Facial emotion discrimination: III. Behavioral findings in schizophrenia. Psychiatry Res (1992) 1.29

Simultaneous detection of multiple cytokines from conditioned media and patient's sera by an antibody-based protein array system. Anal Biochem (2001) 1.27

Molecular cloning, tissue distribution and chromosomal localization of a novel member of the opioid receptor gene family. FEBS Lett (1994) 1.23

Intraneuronal and extracellular neurofibrillary tangles exhibit mutually exclusive cytoskeletal antigens. Ann Neurol (1988) 1.23

DPC4, a candidate tumor suppressor gene, is altered infrequently in head and neck squamous cell carcinoma. Cancer Res (1996) 1.22

Mood effects on limbic blood flow correlate with emotional self-rating: a PET study with oxygen-15 labeled water. Psychiatry Res (1995) 1.21

Reliability, performance characteristics, construct validity, and an initial clinical application of a visual object learning test (VOLT). Neuropsychology (1997) 1.21

In vitro and in vivo characterization of A-796260: a selective cannabinoid CB2 receptor agonist exhibiting analgesic activity in rodent pain models. Br J Pharmacol (2007) 1.20

Age and regional cerebral blood flow at rest and during cognitive activity. Arch Gen Psychiatry (1987) 1.20

Working memory constrains abstraction in schizophrenia. Biol Psychiatry (2000) 1.20

White-spot syndrome virus (WSSV) introduction into the Gulf of Mexico and Texas freshwater systems through imported, frozen bait-shrimp. Dis Aquat Organ (2006) 1.18

Sex differences in aging of the human frontal and temporal lobes. J Neurosci (1994) 1.17

Approaches to cognitive remediation of neuropsychological deficits in schizophrenia: a review and meta-analysis. Neuropsychol Rev (2001) 1.17

Schizophrenia throughout life: sex differences in severity and profile of symptoms. Schizophr Res (1996) 1.16

Parallel loss of presynaptic and postsynaptic dopamine markers in normal aging. Ann Neurol (1998) 1.14

Gender differences in the clinical expression of schizophrenia. Schizophr Res (1992) 1.14

p53 and Egr-1 additively suppress transformed growth in HT1080 cells but Egr-1 counteracts p53-dependent apoptosis. Oncogene (1999) 1.14

Sex differences in brain-behavior relationships between verbal episodic memory and resting regional cerebral blood flow. Neuropsychologia (2000) 1.12

Egr-1 negatively regulates human tumor cell growth via the DNA-binding domain. Cancer Res (1995) 1.12

Connexin 43 (cx43) enhances chemotherapy-induced apoptosis in human glioblastoma cells. Int J Cancer (2001) 1.12

Frontotemporal cerebral blood flow change during executive and declarative memory tasks in schizophrenia: a positron emission tomography study. Neuropsychology (1998) 1.11

Language before and after temporal lobectomy: specificity of acute changes and relation to early risk factors. Epilepsia (1995) 1.10

Induction of changes in the secondary structure of globular proteins by a hydrophobic surface. Eur Biophys J (1993) 1.10

Volunteers for biomedical research. Recruitment and screening of normal controls. Arch Gen Psychiatry (1991) 1.08

P50 abnormalities in schizophrenia: relationship to clinical and neuropsychological indices of attention. Schizophr Res (1998) 1.07

Memory deficits before and after temporal lobectomy: effect of laterality and age of onset. Brain Cogn (1989) 1.05

Reciprocal modulation between Sp1 and Egr-1. J Cell Biochem (1997) 1.05

Adeno-associated viral vector-mediated hypoxia-regulated VEGF gene transfer promotes angiogenesis following focal cerebral ischemia in mice. Gene Ther (2007) 1.05

Brain function in psychiatric disorders. III. Regional cerebral blood flow in unmedicated schizophrenics. Arch Gen Psychiatry (1985) 1.05

Genome scan implicates adhesion biological pathways in secondary leukemia. Leukemia (2007) 1.04

Effects of age on dopamine transporters in healthy humans. J Nucl Med (1999) 1.04

Altered hematopoiesis, behavior, and sexual function in mu opioid receptor-deficient mice. J Exp Med (1997) 1.04

Midlatency auditory evoked responses in schizophrenia. Biol Psychiatry (1991) 1.03

Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium. Mol Psychiatry (2015) 1.03

Proteolytic cleavage of the amino terminus of the U(L)15 gene product of herpes simplex virus type 1 is coupled with maturation of viral DNA into unit-length genomes. J Virol (1999) 1.03

A genome-wide approach identifies that the aspartate metabolism pathway contributes to asparaginase sensitivity. Leukemia (2010) 1.03

Chlamydia trachomatis mouse pneumonitis lung infection in IL-18 and IL-12 knockout mice: IL-12 is dominant over IL-18 for protective immunity. Mol Med (2000) 1.02

Gene expression of transforming growth factor-beta 1 and its type II receptor in giant cell tumors of bone. Possible involvement in osteoclast-like cell migration. Am J Pathol (1994) 1.02

Functional MRI reveals left amygdala activation during emotion. Psychiatry Res (1997) 1.02

Persistent infection with neurotropic herpes viruses and cognitive impairment. Psychol Med (2012) 1.01

Standardized mood induction with happy and sad facial expressions. Psychiatry Res (1994) 1.01

Mining the National Cancer Institute Anticancer Drug Discovery Database: cluster analysis of ellipticine analogs with p53-inverse and central nervous system-selective patterns of activity. Mol Pharmacol (1998) 1.01

Enamel proteases reduce amelogenin-apatite binding. J Dent Res (2008) 1.01

The human cadherin 11 is a pro-apoptotic tumor suppressor modulating cell stemness through Wnt/β-catenin signaling and silenced in common carcinomas. Oncogene (2011) 1.00

TRPC channel-mediated neuroprotection by PDGF involves Pyk2/ERK/CREB pathway. Cell Death Differ (2009) 1.00

Brain function in psychiatric disorders. I. Regional cerebral blood flow in medicated schizophrenics. Arch Gen Psychiatry (1983) 0.99